RMC No. 124-2022: Publishes the August 15, 2022 letter from the Food and Drug Administration of the DOH endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act)

Key points

1. Update to the list. The letter comes from FDA Director General Samuel A. Zacate. The list now includes medicines prescribed for cancer, tuberculosis and mental illness, and corrects medicines prescribed for diabetes and hypertension.
2. When the exemption takes effect. As clarified under Q&A No. 1 of RMC No. 99-2021, the VAT exemption of the covered medicines and medical devices takes effect on the date the FDA publishes the updates to the list.

Deadlines and effectivity

• FDA letter dated August 15, 2022
• VAT exemption effective on the date of FDA publication of the updates